Milan 2012 Programme Registration Exhibition Hotels Exhibitor Listing Satellite Meetings Visa Information
Search Abstracts by author or title
(results will display both Free Papers & Poster)

Initial Hong Kong experience with a new LASIK treatment for presbyopia

Poster Details

First Author: S.Kwok HONG KONG

Co Author(s):    V. Lee   V. Woo           

Abstract Details


Assessment of the safety and efficacy of the SUPRACOR LASIK algorithm for presbyopia correction in presbyopic hyperopes.


Hong Kong Laser Eye Centre, Hong Kong


A multi-surgeon, single centre evaluation of a presbyopic LASIK treatment. Forty one hyperopic presbyopic patients (61 eyes) underwent the SUPRACOR procedure using the TECHNOLAS 217P Excimer Platform (Technolas Perfect Vision). Measured outcomes included uncorrected monocular and binocular near and distance visual acuity (UNVA and UDVA), best corrected distance visual acuity (BSCVA), safety and predictability. The follow-up period is 6 months.


Mean pre-operative spherical equivalent (SE), sphere and cylinder were 1.38±0.76D, 1.56±0.84D and -0.36±0.41D, respectively. At 3 months follow-up (22 eyes) SE, sphere and cylinder were 0.43D, -0,27D and -0.32D. Patients gained an average of 10 lines of near vision, with 78% of patients achieving J2 binocular UNVA (n=9). At 3 months post-op, all patients achieved binocular UDVA of 0.63 or better, with 86% at 0.8 or better. No patients lost more than 1 line of BSCVA.


Preliminary results find the SUPRACOR procedure is safe and effective, providing a good improvement in near vision, with minimal loss of distance vision. Further longer term data will be obtained to verify these findings. FINANCIAL DISCLOSURE?: ... research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, ... travel has been funded, fully or partially, by a competing company

Back to previous

loading Please wait while information is loading.